AnandRathi

Syncom Formulations (India) Ltd Fundamental Analysis

Last Updated Date: 22 Sept 2026
₹20.40
+0.60 (+3.03%)

Syncom Formulations (India) Ltd (Syncom Formul.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹1,918 crore.

Syncom Formulations (India) Ltd Overview

Market cap₹1,918 Crs
Volume6,59,288
Prev. Close₹19.80
Year range₹10.21 - ₹22.52
ISININE312C01025

Syncom Formulations (India) Ltd Fundamentals

ROCE(TTM)24.51%
P/E Ratio (TTM)22.67
P/B Ratio4.65
Debt to Equity0.00
ROE18.43%
EPS (TTM)0.90
Dividend Yield0.49%
Book Value4.39
Profit Margin17.15%
Operating Margin16.27%

Syncom Formulations (India) Ltd Historical Performance

1 Month Return26.39%
6 Month Return81.49%
3 Year Return136.38%
3 Month Return45.82%
1 Year Return16.17%
5 Year Return192.68%

Syncom Formulations (India) Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research